ZOMDF (Zomedica) Cyclically Adjusted FCF per Share: $-0.08 (As of Mar. 2026)


What is Zomedica Cyclically Adjusted FCF per Share?

Zomedica ZOMDF -5.31% Cyclically Adjusted FCF per Share is $-0.08 as of Mar. 2026. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zomedica's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.006. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.08 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-05), Zomedica's current stock price is $0.0945. Zomedica's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-0.08. Zomedica's Cyclically Adjusted Price-to-FCF of today is .


Zomedica  (OTCPK:ZOMDF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zomedica Cyclically Adjusted FCF per Share Related Terms


Zomedica Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Zomedica's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zomedica Cyclically Adjusted FCF per Share Chart

Zomedica Annual Data
Trend Feb16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.08 -0.07 -0.07 -0.08

Zomedica Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.07 -0.08 -0.08 -0.08

ZOMDF vs STIM, OM, RPID: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Zomedica's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zomedica Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zomedica's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zomedica's Cyclically Adjusted Price-to-FCF falls into.



Zomedica Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zomedica's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.006/330.2130*330.2130
=-0.006

Current CPI (Mar. 2026) = 330.2130.

Zomedica Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.011 241.018 -0.015
201609 -0.022 241.428 -0.030
201612 -0.018 241.432 -0.025
201703 -0.020 243.801 -0.027
201706 -0.024 244.955 -0.032
201709 -0.016 246.819 -0.021
201712 -0.022 246.524 -0.029
201803 -0.019 249.554 -0.025
201806 -0.031 251.989 -0.041
201809 -0.041 252.439 -0.054
201812 -0.035 251.233 -0.046
201903 -0.026 254.202 -0.034
201906 -0.078 256.143 -0.101
201909 -0.042 256.759 -0.054
201912 -0.018 256.974 -0.023
202003 -0.018 258.115 -0.023
202006 -0.027 257.797 -0.035
202009 -0.010 260.280 -0.013
202012 -0.004 260.474 -0.005
202103 -0.003 264.877 -0.004
202106 -0.002 271.696 -0.002
202109 -0.005 274.310 -0.006
202112 -0.005 278.802 -0.006
202203 -0.003 287.504 -0.003
202206 -0.005 296.311 -0.006
202209 -0.004 296.808 -0.004
202212 -0.001 296.797 -0.001
202303 -0.009 301.836 -0.010
202306 -0.006 305.109 -0.006
202309 -0.010 307.789 -0.011
202312 -0.007 306.746 -0.008
202403 -0.010 312.332 -0.011
202406 -0.008 314.175 -0.008
202409 -0.006 315.301 -0.006
202412 -0.007 315.605 -0.007
202503 -0.007 319.799 -0.007
202506 -0.006 322.561 -0.006
202509 -0.005 324.800 -0.005
202512 -0.001 324.054 -0.001
202603 -0.006 330.213 -0.006

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.08 mean?
Zomedica (ZOMDF) has a Cyclically Adjusted FCF per Share of $-0.08 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zomedica and its competitors.
Is Zomedica's Cyclically Adjusted FCF per Share too high?
Zomedica's current Cyclically Adjusted FCF per Share is $-0.08.
How does Zomedica's Cyclically Adjusted FCF per Share compare to STIM and OM?
Zomedica's Cyclically Adjusted FCF per Share of $-0.08 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zomedica and its competitors. Zomedica's current Cyclically Adjusted FCF per Share is $-0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zomedica stock overvalued right now?
Based on GuruFocus' analysis, Zomedica (ZOMDF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.19, compared to a current price of $0.09 — trading 50.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-0.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Zomedica (ZOMDF), the current Cyclically Adjusted FCF per Share is $-0.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zomedica Business Description

Address 1101 Technology Drive, Suite 100, Ann Arbor, MI, USA, 48108
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its segments consist of Diagnostics, Therapeutic Devices, and Development Services. It earns the majority of revenue from the therapeutics segment, which consists of Assisi, PulseVet, and VETIGEL products.